BOSTON, May 15, 2025 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the pricing of an…Read More

You might also be interested in reading Bitkub Weighs Hong Kong Listing Amid Mixed Gains for Retail Investors in Crypto IPOs.